Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Gerdts

Showing results (191-200 of 262) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|March 24, 2012
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) StudyAnders M Greve, Eva Gerdts, Kurt Boman, et al.
Reviews in Cardiovascular Medicine|March 29, 2022
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life StudyAlexander Lilja-Cyron, Casper N Bang, Eva Gerdts, et al.
Journal of Hypertension|April 19, 2016
Aortic root dimension and arterial stiffness in arterial hypertension: the Campania Salute NetworkMai Tone Lønnebakken, Raffaele Izzo, Costantino Mancusi, et al.
American Journal of Hypertension|November 11, 2005
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudyMichael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
Journal of the American Heart Association|March 10, 2017
Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)Mai Tone Lønnebakken, Raffaele Izzo, Costantino Mancusi, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 22, 2011
Aortic root geometry in aortic stenosis patients (a SEAS substudy)Edda Bahlmann, Christoph A Nienaber, Dana Cramariuc, et al.
Circulation|January 30, 2013
Prognostic value of energy loss index in asymptomatic aortic stenosisEdda Bahlmann, Eva Gerdts, Dana Cramariuc, et al.
Circulation|July 10, 2002
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) StudyKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
Journal of Hypertension|June 14, 2008
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE studyMarcello Chinali, Giovanni de Simone, Kristian Wachtell, et al.
Circulation|August 25, 2004
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trialRichard B Devereux, Björn Dahlöf, Eva Gerdts, et al.
Pageof 27

Showing results (191-200 of 262) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|March 24, 2012
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) StudyAnders M Greve, Eva Gerdts, Kurt Boman, et al.
Reviews in Cardiovascular Medicine|March 29, 2022
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life StudyAlexander Lilja-Cyron, Casper N Bang, Eva Gerdts, et al.
Journal of Hypertension|April 19, 2016
Aortic root dimension and arterial stiffness in arterial hypertension: the Campania Salute NetworkMai Tone Lønnebakken, Raffaele Izzo, Costantino Mancusi, et al.
American Journal of Hypertension|November 11, 2005
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudyMichael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
Journal of the American Heart Association|March 10, 2017
Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)Mai Tone Lønnebakken, Raffaele Izzo, Costantino Mancusi, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 22, 2011
Aortic root geometry in aortic stenosis patients (a SEAS substudy)Edda Bahlmann, Christoph A Nienaber, Dana Cramariuc, et al.
Circulation|January 30, 2013
Prognostic value of energy loss index in asymptomatic aortic stenosisEdda Bahlmann, Eva Gerdts, Dana Cramariuc, et al.
Circulation|July 10, 2002
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) StudyKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
Journal of Hypertension|June 14, 2008
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE studyMarcello Chinali, Giovanni de Simone, Kristian Wachtell, et al.
Circulation|August 25, 2004
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trialRichard B Devereux, Björn Dahlöf, Eva Gerdts, et al.
Pageof 27